Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
EV/Net Sales

    Back to All Ratios
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year EV/Net Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Net Sales(x) 2.231.411.201.520.90

What is the latest EV/Net Sales ratio of GLENMARK PHARMACEUTICALS ?

The latest EV/Net Sales ratio of GLENMARK PHARMACEUTICALS is 2.23 based on Mar2024 Consolidated results.
Year EV/Net Sales
Mar20242.23
Mar20231.41
Mar20221.20
Mar20211.52
Mar20200.90

How is EV/Net Sales of GLENMARK PHARMACEUTICALS Trending?

Years EV/Net Sales % Change
Mar2024 2.23
58.16
Mar2023 1.41
17.50
Mar2022 1.2
-21.05
Mar2021 1.52
68.89
Mar2020 0.9 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare EV/Net Sales ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹40,842.8 Cr 4.8% 5.2% 40% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹416,273.0 Cr 2.9% 1.8% 14% Stock Analytics
DIVIS LABORATORIES ₹166,750.0 Cr 5.7% 9.6% 58.6% Stock Analytics
CIPLA ₹121,122.0 Cr -0.8% 1.2% 6.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,487.0 Cr 0.8% 1.2% 25.4% Stock Analytics
DR REDDYS LABORATORIES ₹102,680.0 Cr 2.9% 6.5% 4.3% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

4.8%

5.2%

40%

SENSEX

3.6%

9.5%

13.3%


You may also like the below Video Courses